Press/Media
- 1 results
Search results
-
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma
02/8/24
1 item of Media coverage
Press/Media
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Michael Wang, Javier Munoz, Andre Goy, Frederick Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman, Houston Holmes, Samantha Jaglowski, Ian W. Flinn, Peter A. Mcsweeney, David B. Miklos, John M. Pagel, Marie José Kersten, Krimo Bouabdallah, Rashmi Khanal, Roch Houot, Amer Beitinjaneh, Weimin Peng, Xiang Fang
- University of Texas MD Anderson Cancer Center
- Banner Health
- Rutgers - The State University of New Jersey, Newark
- John Theurer Cancer Center
- University of South Florida
- Moffitt Cancer Center
- Dana-Farber Cancer Institute
- Cleveland Clinic Foundation
- Case Western Reserve University
- University of California at Los Angeles
- Texas Oncology
- Ohio State University
- Sarah Cannon Research Institute
- Colorado Blood Cancer Institute
- Stanford University
- Swedish Medical Center
- Swedish Cancer Center
- University of Amsterdam
- Bordeaux University Hospital
- Université de Rennes
- CHU de Rennes
- University of Miami
- Kite, a Gilead Company
- Kite Pharma
- University of Rochester
Research output: Contribution to journal › Article › peer-review
216
Scopus
citations